Li Jin

Li Jin

Auto-generated profile, based on publicly available information

Li Jin

Clinical Research Center for Infectious Diseases of Shaanxi, Xi’an 710061, Shaanxi, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2019 in Cancer Science
Verified
Journal Article
Open access
PDF file
XZXiaoGang Zhang
XiaoGang Zhang
LJLi Jin
Li Jin
ZTZhen Tian
Zhen Tian
JWJing Wang
Jing Wang
YYYuan Yang
Yuan Yang
XZXiaoli Zhang
Xiaoli Zhang
Hepatocellular carcinoma (HCC) is the second most common cause of cancer‐related mortality worldwide. The expression of nitric oxide synthase (NOS) and the inhibition of autophagy have been linked to cancer cell death. However, the involvement of serum nitric oxide (NO), the expression of NOS and autophagy have not been investigated in HCC. In the present study, we first established that the NO level was significantly higher in hepatitis B virus‐related HCC than in the liver cirrhosis control (53.60 ± 19.74 vs 8.09 ± 4.17 μmol/L, t = 15.13, P < 0.0001). Using immunohistochemistry, we found that the source of NO was at least partially attributed to the expression of inducible NOS and endothelial NOS but not neuronal NOS in the liver tissue. Furthermore, in human liver cancer cells, NO‐induced apoptosis and inhibited autophagy. Pharmacological inhibition of autophagy also induced apoptosis, whereas the induction of autophagy could ameliorate NO‐induced apoptosis. We also found that NO regulates the switch between apoptosis and autophagy by disrupting the Beclin 1/Vps34 association and by increasing the Bcl‐2/Beclin 1 interaction. Overall, the present findings suggest that increased NOS/NO promotes apoptosis through the inhibition of autophagy in liver cancer cells, which may provide a novel strategy for the treatment of HCC.

1 March 2022 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
LJLi Jin
Li Jin
JLJuan Li
Juan Li
SYShuJuan Yang
ShuJuan Yang
RZRou Zhang
Rou Zhang
CHChunHua Hu
ChunHua Hu
TYTaoTao Yan
TaoTao Yan
LPS inhibits autophagy in a concentration- and dose-dependent manner in HSC-T6 cells. MAPK p38 induces phosphorylation of Ulk1, which disrupts the Ulk1-Atg13 complex and is therefore required for the inhibition of autophagy by LPS. LPS induces IL-1β expression via the MAPK p38/Ulk1 pathway in HSCs.

8 October 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
WWWenjia Wang
Wenjia Wang
JLJin Li
Jin Li
LLLan Lan
Lan Lan
LXLinyi Xie
Linyi Xie
FXFen Xiong
Fen Xiong
QWQiuju Wang
Qiuju Wang
Objective: The objective of this study is to analyze the genotype–phenotype correlation of patients with auditory neuropathy (AN), which is a clinical condition featuring normal cochlear responses and abnormal neural responses, and ATP1A3 c.2452 G > A (p.E818K), which has been generally recognized as a genetic cause of cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome.Methods: Four patients diagnosed as AN by clinical evaluation and otoacoustic emission and auditory brainstem responses were recruited and analyzed by next-generation sequencing to identify candidate disease-causing variants. Sanger sequencing was performed on the patients and their parents to verify the results, and short tandem repeat-based testing was conducted to confirm the biological relationship between the parents and the patients. Furthermore, cochlear implantation (CI) was performed in one AN patient to reconstruct hearing.Results: Four subjects with AN were identified to share a de novo variant, p.E818K in the ATP1A3 gene. Except for the AN phenotype, patients 1 and 2 exhibited varying degrees of neurological symptoms, implying that they can be diagnosed as CAPOS syndrome. During the 15 years follow-up of patient 1, we observed delayed neurological events and progressive bilateral sensorineural hearing loss in pure tone threshold (pure tone audiometry, PTA). Patient 2 underwent CI on his left ear, and the result was poor. The other two patients (patient 3 and patient 4, who were 8 and 6 years old, respectively) denied any neurological symptoms.Conclusion:ATP1A3 p.E818K has rarely been documented in the Chinese AN population. Our study confirms that p.E818K in the ATP1A3 gene is a multiethnic cause of AN in Chinese individuals. Our study further demonstrates the significance of genetic testing for this specific mutation for identifying the special subtype of AN with somewhat favorable CI outcome and offers a more accurate genetic counseling about the specific de novo mutation.

5 September 2023 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
SYShi-Feng Yang
Shi-Feng Yang
XXXin-Fang Xie
Xin-Fang Xie
WLWan-Hong Lu
Wan-Hong Lu
PLPing Lan
Ping Lan
HLHui Liu
Hui Liu
LJLi Jin
Li Jin

27 October 2025 in Renal Failure
Verified
Journal Article
Open access
XDXiangyun Dang
Xiangyun Dang
GXGuiqing Xu
Guiqing Xu
HLHuixian Li
Huixian Li
YHYiqun Hao
Yiqun Hao
XZXiaotian Zhang
Xiaotian Zhang
LJLi Jin
Li Jin
Chronic kidney disease (CKD) is closely linked to systemic inflammation and accelerated cellular aging. However, the role of the systemic inflammation response index (SIRI) and leukocyte telomere length (LTL), a biomarker of cellular aging, in the development and progression of CKD remain incompletely elucidated. We analyzed cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) (1999-2002), which included 3805 individuals. Participants were divided into subgroups: (1) CKD versus non-CKD and (2) SIRI quartiles (Q1-Q4). SIRI was calculated as (monocytes × neutrophils)/lymphocytes. CKD was defined by urinary albumin to creatinine ratio (UACR) ≥30 mg/g or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2. LTL was quantified by quantitative polymerase chain reaction (qPCR). Weighted logistic regression models used to assess the associations of SIRI, LTL, and CKD, adjusting for demographics, socioeconomic factors, lifestyle, and comorbidities. Mediation analysis was performed to quantify the indirect effect of SIRI on CKD via LTL shortening. Participants with CKD exhibited significantly higher SIRI values (p < 0.001) and shorter LTL (p < 0.001) compared those without CKD. In fully adjusted models, higher SIRI quartiles showed a dose-response relationship with CKD risk: Q3 (OR = 1.442, p = 0.046) and Q4 (OR = 2.165, p < 0.001). Conversely, longer LTL was inversely associated with CKD risk across quartiles: Q2 (OR = 0.681, p = 0.047), Q3 (OR = 0.567, p = 0.015), and Q4 (OR = 0.445, p = 0.004). Furthermore, higher SIRI quartiles showed significant inverse associations with LTL compared to Q1: Q3 (OR = 0.955, p = 0.040) and Q4 (OR = 0.944, p = 0.007). Mediation analysis showed that LTL mediated 7.8% (95% CI: 4.12%, 15.63%) of the total effect of SIRI on CKD (indirect effect: OR = 1.002, p < 0.001), while the direct effect remained statistically significant (OR = 1.026, p < 0.001). Sensitivity analyses verified the robustness of the results. Systemic inflammation, as quantified by the SIRI, has a significant impact on CKD risk through its contribution to LTL attrition. This process highlights the complex interplay between systemic inflammation and biological aging in the pathophysiology of CKD.

21 January 2026 in Journal of Medical Microbiology
Verified
Journal Article
Open access
SYShujuan Yang
Shujuan Yang
JWJing Wang
Jing Wang
NYNan Yang
Nan Yang
JLJuan Li
Juan Li
LJLi Jin
Li Jin
XZXiaoli Zhang
Xiaoli Zhang
Introduction. The correlation between antibiotic exposure and adverse outcomes in patients with acute-on-chronic liver failure (ACLF) remains controversial, and the underlying mechanism is unclear. Hypothesis/Gap Statement. This study hypothesizes that antibiotic exposure in ACLF patients alters gut microbiota, which affects the outcome of ACLF. Aim. To explore the effect of antibiotic exposure on gut microbiota that affects the outcome of ACLF. Methodology. A retrospective matched study of ACLF patients and the ACLF rat model was used to assess adverse outcomes associated with antibiotic exposure. The gut microbiota of the ACLF patients and the ACLF rat model were sequenced using the Illumina MiSeq platform. Results. Twenty-three ACLF patients who were exposed to antibiotics and 46 matched controls who were not exposed to antibiotics were enrolled. The survival rates at 4, 12 and 24 weeks were significantly lower in the exposure group than in the non-exposure group. In the ACLF rat model, hepatitis in the antibiotic-exposure group became more severe, and the alanine transaminase levels were higher than those of the non-exposure group. The gut microbiota diversity was decreased in the ACLF patients with antibiotic exposure, and the proportions of Enterococcaceae and Peptostreptococcaceae were increased, while those of Lachnospiraceae , Bifidobacteriaceae and Bacteroidaceae were decreased. In the rat model, antibiotic exposure induced Gram-positive and Gram-negative bacterial eradication, and Klebsiella became the dominant micro-organism. Conclusion. Antibiotic exposure aggravated hepatitis and had no survival benefit for ACLF. The underlying mechanism may be related to dysbiosis in the gut microbiota.